Investment in Automated Optical Inspection (AOI) system to assure quality of medical device PCB’s

Kent-based design, development and manufacturing partner, ITL Group (a Gooch & Housego company), announces further investment in its in-house SMT manufacturing facility, using optical inspection and electrical testing to boost quality of medical device PCB’s.

Headquartered in Kent, UK, ITL is an ISO 13485 and ISO 9001 accredited company offering world-class design and manufacturing services to the medical and life science sectors. In the MedTech industry quality and precision are crucial, so as device designs become more complex, the need for advanced inspection becomes critical.

The equipment upgrade includes an Automated Optical Inspection (AOI) system set to become inline as part of the company’s SMT process, and an SMD component tester, to ensure the quality of electrical components before placement.

The ALD770S i3D Inline AOI is one of the fastest and most accurate machines available on the market. It is designed to overcome all PCB design challenges including shadows, different component colours, PCB warp and more.

Tristan Lambert, Production Manager at ITL commented,

“The investment in the ALD770S i3D AOI reflects our focus on assuring the quality of finished medical devices. We understand that optical inspection is an essential part of the quality process in manufacturing, that’s why we continue to invest heavily in the latest technologies to assure our customers have confidence in the quality of our PCB’s.”

The component tester can measure resistors, capacitors, diodes and inductors with voltages up to 40V. It can be programmed to test all components prior to placement, or the first and last components to verify correct feeder loading.

All test data is held at component level providing control and, where necessary, traceability at individual circuit level, giving customers and end-users confidence that ITL has completed the process within design and production limits.

Tristan comments,

“Continuous improvement has been a guiding force for ITL since the beginning, this recent investment in new equipment ensures quality, increases accuracy and prevents potential errors from occurring.”

Medical PCB Manufacturing with ITL

With over 40 years’ experience in PCB assembly, we are one of the few ISO 13485 and FDA GMP certified UK manufacturers that can provide high volume PCB manufacturing within the medical sector.

Our PCB manufacturing process has been validated in accordance with FDA GMP 21 CFR Part 820 and our automated build and inspection equipment verifies that all PCB’s are manufactured and perform to the highest standards. Of course, not everything is suitable for automation – that’s why we have a skilled team of through-hole technicians too. Whatever the scale of your medical device project, we can help.

Contact us

If you’re looking for advice, would like to enquire about our PCB manufacturing services or you’d simply like to talk through your project with one of our experts, then we’d love to hear from you - contact us.

Subscribe/Follow

Don’t miss out on the latest news and resources, subscribe to our mailing list.

You may also like...

News
Students show their enthusiasm for STEM at Bright Spark Awards

On Friday 5th July, schools from across Kent and London gathered at Discovery Park in Sandwich to compete centre stage at the 2019 Bright Spark Awards. Business Development Manager, Tom Ackrill and Marketing Coordinator, Becky Lipscombe represented ITL Group (a G&H company) at the ‘dragons-den’ style event organised by the KM Charity Team and Inspire Schools.

Read more >

Resource
Applying a regulatory approach – a guide for medical device startups

To ensure product quality and patient safety, medical device manufacturers must adhere to specific regulatory requirements and comply with rigorous safety standards. Are you aware of the regulatory approach necessary to compliantly manage your device from concept through to commercialisation?

Read more >

Case Study
Magnasense

From lab based analysis to mobile and disposable ‘point of care testing’ (POCT)

View this case study >